National Health Investors, Inc.
NHI
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 18.84 | -14.46% |
| 2024 | 22.02 | 23.27% |
| 2023 | 17.86 | -82.38% |
| 2022 | 101.39 | 140.01% |
| 2021 | 42.25 | 84.97% |
| 2020 | 22.84 | -32.76% |
| 2019 | 33.96 | 65.44% |
| 2018 | 20.53 | 6.14% |
| 2017 | 19.34 | 1.30% |
| 2016 | 19.09 | 24.18% |
| 2015 | 15.38 | -33.09% |
| 2014 | 22.98 | 53.36% |
| 2013 | 14.98 | -13.52% |
| 2012 | 17.33 | 15.32% |
| 2011 | 15.03 | -16.25% |
| 2010 | 17.94 | 12.92% |
| 2009 | 15.89 | 20.22% |
| 2008 | 13.21 | 64.87% |
| 2007 | 8.02 | -39.40% |
| 2006 | 13.23 | 0.07% |
| 2005 | 13.22 | -6.32% |
| 2004 | 14.11 | -7.06% |
| 2003 | 15.18 | 9.87% |
| 2002 | 13.82 | -100.24% |
| 2001 | -5.75K | -107,814.77% |
| 2000 | 5.34 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 120.30 | 538.66% |
US
|
|
| 153.29 | 713.83% |
US
|
|
| 15.60 | -17.17% |
US
|
|
| 53.54 | 184.26% |
US
|
|
| 77.01 | 308.85% |
US
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.